BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 25974282)

  • 1. Lung microbiota across age and disease stage in cystic fibrosis.
    Coburn B; Wang PW; Diaz Caballero J; Clark ST; Brahma V; Donaldson S; Zhang Y; Surendra A; Gong Y; Elizabeth Tullis D; Yau YC; Waters VJ; Hwang DM; Guttman DS
    Sci Rep; 2015 May; 5():10241. PubMed ID: 25974282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
    Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
    J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airway microbiota across age and disease spectrum in cystic fibrosis.
    Zemanick ET; Wagner BD; Robertson CE; Ahrens RC; Chmiel JF; Clancy JP; Gibson RL; Harris WT; Kurland G; Laguna TA; McColley SA; McCoy K; Retsch-Bogart G; Sobush KT; Zeitlin PL; Stevens MJ; Accurso FJ; Sagel SD; Harris JK
    Eur Respir J; 2017 Nov; 50(5):. PubMed ID: 29146601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Evolving Cystic Fibrosis Microbiome: A Comparative Cohort Study Spanning 16 Years.
    Acosta N; Whelan FJ; Somayaji R; Poonja A; Surette MG; Rabin HR; Parkins MD
    Ann Am Thorac Soc; 2017 Aug; 14(8):1288-1297. PubMed ID: 28541746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic footprint of the airway bacterial community in cystic fibrosis.
    Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
    Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.
    Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD
    PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of the Nasopharyngeal Microbiota in Infants with Cystic Fibrosis.
    Prevaes SM; de Winter-de Groot KM; Janssens HM; de Steenhuijsen Piters WA; Tramper-Stranders GA; Wyllie AL; Hasrat R; Tiddens HA; van Westreenen M; van der Ent CK; Sanders EA; Bogaert D
    Am J Respir Crit Care Med; 2016 Mar; 193(5):504-15. PubMed ID: 26492486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation.
    Nguyen LD; Deschaght P; Merlin S; Loywick A; Audebert C; Van Daele S; Viscogliosi E; Vaneechoutte M; Delhaes L
    PLoS One; 2016; 11(12):e0168860. PubMed ID: 28030619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis.
    Armbruster CR; Li K; Kiedrowski MR; Zemke AC; Melvin JA; Moore J; Atteih S; Fitch AC; DuPont M; Manko CD; Weaver ML; Gaston JR; Alcorn JF; Morris A; Methé BA; Lee SE; Bomberger JM
    Microbiol Spectr; 2022 Oct; 10(5):e0125122. PubMed ID: 36094193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergence of bacterial communities in the lower airways of CF patients in early childhood.
    O'Connor JB; Mottlowitz MM; Wagner BD; Boyne KL; Stevens MJ; Robertson CE; Harris JK; Laguna TA
    PLoS One; 2021; 16(10):e0257838. PubMed ID: 34613995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis.
    Flight WG; Smith A; Paisey C; Marchesi JR; Bull MJ; Norville PJ; Mutton KJ; Webb AK; Bright-Thomas RJ; Jones AM; Mahenthiralingam E
    J Clin Microbiol; 2015 Jul; 53(7):2022-9. PubMed ID: 25878338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.
    Kolpen M; Kragh KN; Bjarnsholt T; Line L; Hansen CR; Dalbøge CS; Hansen N; Kühl M; Høiby N; Jensen PØ
    Int J Med Microbiol; 2015 Jan; 305(1):1-10. PubMed ID: 25441256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.
    de Dios Caballero J; Vida R; Cobo M; Máiz L; Suárez L; Galeano J; Baquero F; Cantón R; Del Campo R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28951476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
    Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
    Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in cystic fibrosis airway microbial community associated with a severe decline in lung function.
    Paganin P; Fiscarelli EV; Tuccio V; Chiancianesi M; Bacci G; Morelli P; Dolce D; Dalmastri C; De Alessandri A; Lucidi V; Taccetti G; Mengoni A; Bevivino A
    PLoS One; 2015; 10(4):e0124348. PubMed ID: 25898134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease.
    Hogan DA; Willger SD; Dolben EL; Hampton TH; Stanton BA; Morrison HG; Sogin ML; Czum J; Ashare A
    PLoS One; 2016; 11(3):e0149998. PubMed ID: 26943329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging cystic fibrosis pathogens and the microbiome.
    Mahenthiralingam E
    Paediatr Respir Rev; 2014 Jun; 15 Suppl 1():13-5. PubMed ID: 24832700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of inhaled aztreonam on the cystic fibrosis lung microbiome.
    Heirali AA; Workentine ML; Acosta N; Poonja A; Storey DG; Somayaji R; Rabin HR; Whelan FJ; Surette MG; Parkins MD
    Microbiome; 2017 May; 5(1):51. PubMed ID: 28476135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.